Status:
RECRUITING
Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
Lead Sponsor:
Jiexiong Feng
Conditions:
Pulmonary Sequestration
Congenital Pulmonary Airway Malformation
Eligibility:
All Genders
3-14 years
Phase:
NA
Brief Summary
To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.
Detailed Description
Preoperative preparation Preoperative evaluation of pulmonary ventilation function and enhanced CT examination of the lungs were performed. Respiratory symptoms should be improved first in case of com...
Eligibility Criteria
Inclusion Criteria:
- children with congenital lung malformations diagnosed by CT or MRI scan
Exclusion Criteria:
- 1. ages <3 months and >14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2050
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06302985
Start Date
March 1 2024
End Date
December 31 2050
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430030